Angiotensin II type 1 receptor blockers prevent aortic arterial stiffness in elderly patients with hypertension

References

• Wang S, Liang B, Viollet B, Zou MH. Inhibition of the AMP-activated protein kinase-alpha2 accentuates agonist-induced vascular smooth muscle contraction and high blood pressure in mice. Hypertension. 2011;57:1010–17. doi:10.1161/HYPERTENSIONAHA.110.168906.
   PubMed Web of Science ®Google Scholar
• Wang S, Xu J, Song P, Viollet B, Zou M-H. In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I. Diabetes. 2009;58:1893–901. doi:10.2337/db09-0267.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang C, Zhang M, Liang B, Zhu H, Lee J, Viollet B, Xia L, Zhang Y, Zou M-H. Activation of AMP-activated protein kinase alpha2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo. Nat Med. 2012;18:902–10. doi:10.1038/nm.2711.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang M, Liang B, Xu J, Xie Z, Liu C, Viollet B, Yan D, Zou M-H. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ Res. 2010;106:1117–28. doi:10.1161/CIRCRESAHA.109.212530.
   PubMed Web of Science ®Google Scholar
• Kampus P, Muda P, Kals J, Ristimäe T, Fischer K, Teesalu R, Zilmer M. The relationship between inflammation and arterial stiffness in patients with essential hypertension. Int J Cardiol. 2006;112:46–51. doi:10.1016/j.ijcard.2005.08.026.
   PubMed Web of Science ®Google Scholar
• van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, Hoeks AP, van der Kuip DA, Hofman A, Witteman JC. Association between arterial stiffness and atherosclerosis: the Rotterdam study. Stroke. 2001;32:454–60.
   PubMed Web of Science ®Google Scholar
• Leblanc C, Strong HR, Tabrizchi R. Evaluation of different metrics as an index for the assessment of arterial stiffness. Clin Exp Hypertens. 2018;40:390–7.
   Web of Science ®Google Scholar
• Wang S, Xu J, Song P, Wu Y, Zhang J, Chul Choi H, Zou M-H. Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure. Hypertension. 2008;52:484–90. doi:10.1161/HYPERTENSIONAHA.108.112094.
   PubMed Web of Science ®Google Scholar
• Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–41.
   PubMed Web of Science ®Google Scholar
• Zhu ML, Yin YL, Ping S, Yu H-Y, Wan G-R, Jian X, Li P. Berberine promotes ischemia-induced angiogenesis in mice heart via upregulation of microRNA-29b. Clin Exp Hypertens. 2017;39:672–79. doi:10.1080/10641963.2017.1313853.
   PubMed Web of Science ®Google Scholar
• Ihm SH, Jeon HK, Chae SC, Lim D-S, Kim K-S, Choi D-J, Ha J-W, Kim D-S, Kim KH, Cho M-C, et al. Benidipine has effects similar to losartan on the central blood pressure and arterial stiffness in mild to moderate essential hypertension. Chin Med J (Engl). 2013;126:2021–28.
   PubMed Web of Science ®Google Scholar
• Larstorp AC, Ariansen I, Gjesdal K, Olsen MH, Ibsen H, Devereux RB, Okin PM, Dahlöf B, Kjeldsen SE, Wachtell K. Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study. Hypertension. 2012;60:347–53. doi:10.1161/HYPERTENSIONAHA.112.195032.
   PubMed Web of Science ®Google Scholar
• Tsioufis C, Dimitriadis K, Selima M, Thomopoulos C, Mihas C, Skiadas I, Tousoulis D, Stefanadis C, Kallikazaros I. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. Eur Heart J. 2007;28:1162–69. doi:10.1093/eurheartj/ehm089.
   PubMed Web of Science ®Google Scholar
• Cheng YB, Li Y, Sheng CS, Huang Q-F, Wang J-G. Quantification of the interrelationship between Brachial-Ankle and Carotid-Femoral pulse wave velocity in a workplace population. Pulse (Basel). 2016;3:253–62. doi:10.1159/000444645.
   PubMedGoogle Scholar
• Ambrosino P, Lupoli R, Tortora A, Cacciapuoti M, Lupoli GA, Tarantino P, Nasto A, Di Minno MND. Cardiovascular risk markers in patients with primary aldosteronism: A systematic review and meta-analysis of literature studies. Int J Cardiol. 2016;208:46–55. doi:10.1016/j.ijcard.2016.01.200.
   PubMed Web of Science ®Google Scholar
• Montero D, Roche E, Martinez-Rodriguez A. The impact of aerobic exercise training on arterial stiffness in pre- and hypertensive subjects: a systematic review and meta-analysis. Int J Cardiol. 2014;173:361–68. doi:10.1016/j.ijcard.2014.03.072.
   PubMed Web of Science ®Google Scholar
• Safar ME, Blacher J, Jankowski P. Arterial stiffness, pulse pressure, and cardiovascular disease-is it possible to break the vicious circle? Atherosclerosis. 2011;218:263–71. doi:10.1016/j.atherosclerosis.2011.04.039.
   PubMed Web of Science ®Google Scholar
• Ouyang A, Garner TB, Fleenor BS. Hesperidin reverses perivascular adipose-mediated aortic stiffness with aging. Exp Gerontol. 2017;97:68–72. doi:10.1016/j.exger.2017.08.003.
   PubMed Web of Science ®Google Scholar
• Cheng HM, Park S, Huang Q, Hoshide S, Wang J-G, Kario K, Park C-G, Chen C-H. Vascular aging and hypertension: implications for the clinical application of central blood pressure. Int J Cardiol. 2017;230:209–13. doi:10.1016/j.ijcard.2016.12.170.
   PubMed Web of Science ®Google Scholar
• Di Giosia P, Passacquale G, Petrarca M, Giorgini P, Marra AM, Ferro A. Gender differences in cardiovascular prophylaxis: focus on antiplatelet treatment. Pharmacol Res. 2017;119:36–47. doi:10.1016/j.phrs.2017.01.025.
   PubMed Web of Science ®Google Scholar
• Arnold AP, Cassis LA, Eghbali M, Reue K, Sandberg K. Sex hormones and sex chromosomes cause sex differences in the development of cardiovascular diseases. Arterioscler Thromb Vasc Biol. 2017;37:746–56. doi:10.1161/ATVBAHA.116.307301.
   PubMed Web of Science ®Google Scholar
• Stuenkel CA. Menopause, hormone therapy and diabetes. Climacteric. 2017;20:11–21. doi:10.1080/13697137.2016.1267723.
   PubMed Web of Science ®Google Scholar
• Gilbert EL, Ryan MJ. Estrogen in cardiovascular disease during systemic lupus erythematosus. Clin Ther. 2014;36:1901–12. doi:10.1016/j.clinthera.2014.07.021.
   PubMed Web of Science ®Google Scholar
• Li P, Yin YL, Guo T, Sun X-Y, Ma H, Zhu M-L, Zhao F-R, Xu P, Chen Y, Wan G-R, et al. Inhibition of aberrant MicroRNA-133a expression in endothelial cells by statin prevents endothelial dysfunction by targeting GTP cyclohydrolase 1 in vivo. Circulation. 2016;134:1752–65. doi:10.1161/CIRCULATIONAHA.116.017949.
   PubMed Web of Science ®Google Scholar
• Wang F, Ma H, Liang WJ, Yang -J-J, Wang X-Q, Shan M-R, Chen Y, Jia M, Yin Y-L, Sun X-Y, et al. Lovastatin upregulates microRNA-29b to reduce oxidative stress in rats with multiple cardiovascular risk factors. Oncotarget. 2017;8:9021–34. doi:10.18632/oncotarget.14462.
   PubMedGoogle Scholar
• Yin YL, Zhu ML, Wan J, Zhang C, Pan G-P, Lu J-X, Ping S, Chen Y, Zhao F-R, Yu H-Y, et al. Traditional Chinese medicine xin-mai-jia recouples endothelial nitric oxide synthase to prevent atherosclerosis in vivo. Sci Rep. 2017;7:43508. doi:10.1038/srep43508.
   PubMed Web of Science ®Google Scholar
• Ma H, Liang WJ, Shan MR, Wang X-Q, Zhou S-N, Chen Y, Guo T, Li P, Yu H-Y, Liu C, et al. Pravastatin activates activator protein 2 alpha to augment the angiotensin II-induced abdominal aortic aneurysms. Oncotarget. 2017;8:14294–305. doi:10.18632/oncotarget.15104.
   PubMedGoogle Scholar
• Wang J, Guo T, Peng QS, Yue S-W, Wang S-X. Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice. J Cell Mol Med. 2015;19:2607–16. doi:10.1111/jcmm.12645.
   PubMed Web of Science ®Google Scholar
• Rakugi H, Tsuchihashi T, Shimada K, Numaguchi H, Nishida C, Yamaguchi H, Shirakawa M, Azuma K, Fujita KP. Efficacy and safety of fixed-dose losartan/hydrochlorothiazide/amlodipine combination versus losartan/hydrochlorothiazide combination in Japanese patients with essential hypertension. Clin Exp Hypertens. 2015;37:260–66. doi:10.3109/10641963.2014.954712.
   PubMed Web of Science ®Google Scholar
• Uchiwa H, Kai H, Iwamoto Y, Anegawa T, Kajimoto H, Fukuda K, Imaizumi T, Fukumoto Y. Losartan/hydrochlorothiazide combination is safe and effective for morning hypertension in very-elderly patients. Clin Exp Hypertens. 2018;40:267–73. doi:10.1080/10641963.2017.1368536.
   PubMed Web of Science ®Google Scholar